175 related articles for article (PubMed ID: 18690324)
1. Diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
Mofidi M; Moghadam A
Saudi Med J; 2008 Aug; 29(8):1206-7. PubMed ID: 18690324
[No Abstract] [Full Text] [Related]
2. Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome.
van Noord C; Hooijkaas H; Dufour-van den Goorbergh BC; van Hagen PM; van Daele PL; van de Merwe JP
Ann Rheum Dis; 2005 Jan; 64(1):160-2. PubMed ID: 15608321
[No Abstract] [Full Text] [Related]
3. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
Kitahara K; Takagi K; Kusunoki Y; Nishio S; Nozaki T; Inomata H; Takei M; Sawada S; Kawai S
Ann Rheum Dis; 2008 Jul; 67(7):1059-60. PubMed ID: 18556455
[No Abstract] [Full Text] [Related]
4. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
5. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
[No Abstract] [Full Text] [Related]
6. The role of anti-cyclic citrullinated peptide antibodies in predicting rheumatoid arthritis.
Rexhepi S; Rexhepi M; Sahatçiu-Meka V; Tafaj A; Izairi R; Rexhepi B
Reumatizam; 2011; 58(1):12-4. PubMed ID: 21751570
[TBL] [Abstract][Full Text] [Related]
7. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
Bas S
Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
Lee AN; Beck CE; Hall M
Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
[TBL] [Abstract][Full Text] [Related]
10. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
11. Anti-CCP antibodies, rheumatoid factors and anti-keratin antibodies: clinical value in established rheumatoid arthritis.
Amri M; Sfar I; Ounallah HS; Dhaouadi T; Bel Hadj N; Abdelmoula L; Zouari R; Ayed K; Gorgi Y
Tunis Med; 2011 Mar; 89(3):231-5. PubMed ID: 21387224
[TBL] [Abstract][Full Text] [Related]
12. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
Jansen TL
Ned Tijdschr Geneeskd; 2003 Apr; 147(15):729-30; author reply 730-1. PubMed ID: 12722537
[No Abstract] [Full Text] [Related]
13. Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis.
Jansen TL; Bruyn GA
J Rheumatol; 2004 May; 31(5):1012-3; author reply 1013. PubMed ID: 15124273
[No Abstract] [Full Text] [Related]
14. [Anti-cyclic citrullinated peptide antibody as a serological marker for the diagnosis of rheumatoid arthritis].
Suzuki K
Nihon Rinsho; 2005 Jan; 63 Suppl 1():341-3. PubMed ID: 15799374
[No Abstract] [Full Text] [Related]
15. [Anti-CCP antibody test: diagnostic and pronostic values in rheumatoid arthritis].
Tant L; Steinfeld S
Rev Med Brux; 2006; 27(2):95-8. PubMed ID: 16736847
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of a new fluorometric immunoassay for the detection of anti-cyclic citrullinated peptides autoantibodies in rheumatoid arthritis].
Dubois-Galopin F; Masson C; Chevailler A
Ann Biol Clin (Paris); 2006; 64(2):162-5. PubMed ID: 16556527
[TBL] [Abstract][Full Text] [Related]
17. A combined diagnostic approach to rheumatoid arthritis using anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
Oommen S; Appalaraju B; Sivadarshini S;
Indian J Med Microbiol; 2011; 29(2):195-6. PubMed ID: 21654124
[No Abstract] [Full Text] [Related]
18. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
Ménard HA
J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
[No Abstract] [Full Text] [Related]
19. Low level (below cutoff) of anti-cyclic citrullinated peptide test results in diagnosis of rheumatoid arthritis in a high-risk population.
Kim DA; Kim TY
J Rheumatol; 2010 Jan; 37(1):208. PubMed ID: 20040646
[No Abstract] [Full Text] [Related]
20. Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis.
Nakamura H; Kawakami A; Ida H; Origuchi T; Matsuoka N; Tsuboi M; Furuyama M; Mizokami A; Tsukada T; Nakashima M; Ejima E; Hamasaki K; Aoyagi K; Uetani M; Fukuda T; Honda S; Urayama S; Kawabe Y; Ueki Y; Mine M; Eguchi K
Scand J Rheumatol; 2005; 34(6):489-90. PubMed ID: 16393775
[No Abstract] [Full Text] [Related]
[Next] [New Search]
